Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Lafay
Jean Lafay, Nice FR
| Patent application number | Description | Published |
|---|---|---|
| 20090023779 | Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents - The present invention relates to compounds of formula (I): | 01-22-2009 |
| 20090286863 | SULFAMATOBENZOTHIOPHENE DERIVATIVES - The invention relates to novel compound of the general formula (I), in which R has the meanings indicated in Claim | 11-19-2009 |
| 20100168217 | SULFAMATOBENZOTHIOPHENE DERIVATIVES - The invention relates to novel compound of the general formula (I), in which R has the meanings indicated in claim | 07-01-2010 |
Sophie Lafay, Montagne FR
| Patent application number | Description | Published |
|---|---|---|
| 20100047372 | ANTIOXIDANT AND PHYSICAL PERFORMANCE EFFECTS OF A GRAPE EXTRACT - A method of enhancing physical performance during exercise by administering an amount of a grape extract effective to treat a subject. A preferred grape extract comprises a concentration of flavanol monomers of greater than about 5% by weight, and more preferably within a range from about 12% by weight to about 50% by weight, and a concentration of flavanol dimers preferably greater than about 2% by weight, and more preferably within a range from about 6% by weight to about 20% by weight. The flavanol monomers preferably include catechin, epicatechin, epicatechin gallate, and gallic acid. The flavanol dimers preferably include procyanidin B1, procyanidin B2, procyanidin B3, procyanidin B4, and procyanidin B2-O-gallate. | 02-25-2010 |
| 20100112098 | EFFECTS OF A DECAFFEINATED GREEN COFFEE EXTRACT ON BODY WEIGHT CONTROL BY REGULATION OF GLUCOSE METABOLISM - A method of controlling body weight in humans by administering an amount of decaffeinated green coffee extract effective to treat a subject. A preferred green coffee extract contains a ratio of 5-caffeoylquinic acid (5-CQA) and total chlorogenic acids (tCGA) (5-CQA/tCGA) of between about 0.2 and 0.3. More preferably, the concentration of tCGA is greater than about 45% and the concentration of 5-CQA is less than about 10%. A preferred method of administration consists of administering between about 200 mg and about 1,000 mg per day, more preferably administering about 400 mg per day. | 05-06-2010 |
William T. Lafay, Redondo Beach, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080301861 | THERMALLY PROTECTIVE SURVIVAL GARMENT - A thermally protective coveralls style suit having a plurality of separate water trapping regions between the suit and a user. The suit has a front slide fastener from crotch to neck with water entry retarding arm closures at the wrists and leg closures at ankles or thighs forming water trapping regions, leaving hands and feet free for swimming. Upper and lower chest straps cooperate forming water trapping regions by blocking pocket or water exchange between upper and lower torso regions. Permissive water entry at wrists, ankles or thighs, and neck or face, without circulation or exchange to surrounding water, allows separate pockets or thin film layers of water in the upper, lower, and central torso regions to insulate the body somewhat like a wetsuit where a single film provides insulation. An optional hood is provided to form another pocket or thin film layer without water circulation. Floatation pads assist buoyancy. A jacket embodiment is truncated at the lower chest strap. | 12-11-2008 |